INS and type 2 diabetes mellitus: In a retrospective analysis of the Malaysian primary care-based National Diabetes Registry, among non-insulin-treated patients with T2D and HbA1c ≥8% (64 mmol/mol), 54% had delayed treatment intensification with a median time of 13 months [35].